AptaBio Therapeutics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Jin Soo
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 20.8% |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
Recent updates
Is AptaBio Therapeutics (KOSDAQ:293780) Using Too Much Debt?
Jul 12Here's Why AptaBio Therapeutics (KOSDAQ:293780) Can Manage Its Debt Despite Losing Money
Mar 26Do Institutions Own AptaBio Therapeutics Inc. (KOSDAQ:293780) Shares?
Feb 23Companies Like AptaBio Therapeutics (KOSDAQ:293780) Can Afford To Invest In Growth
Jan 01CEO
Jin Soo
no data
Tenure
Dr. Soo Jin Lee, Ph.D. serves as Chief Executive Officer of AptaBio Therapeutics Inc. Dr. Lee is highly experienced in drug discovery and management for pharmaceutical research and development. She has ove...